David Pugatch

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

Edward Gane, Eric Lawitz, David Pugatch et al. · New England Journal of Medicine · 2017 · 398 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Depressive Symptoms as a Predictor of Sexual Risk among African American Adolescents and Young Adults

Larry K. Brown, Marina Tolou‐Shams, Celia M. Lescano et al. · Journal of Adolescent Health · 2006 · 196 citations

Medicine, Psychiatry, Psychology +17

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

Kazuaki Chayama, Fumitaka Suzuki, Yoshiyasu Karino et al. · Journal of Gastroenterology · 2017 · 116 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

Hiromitsu Kumada, Tsunamasa Watanabe, Fumitaka Suzuki et al. · Journal of Gastroenterology · 2017 · 115 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

Hidenori Toyoda, Kazuaki Chayama, Fumitaka Suzuki et al. · Hepatology · 2017 · 113 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17